Paxlovid does not increase risk of COVID reinfection: study

Published Date: 16 Feb 2023

Although there are concerns that the use of Paxlovid increases the risk of COVID-19 returning, the results are clear.

Read Full News

Latest News

DEI Bans Won’t Erase Health Disparities

Dr George Lundberg explains why treating equity as a banned political buzzword undermines the very foundations of public health and medical care.

Tegoprazan TRIUMpHs Over PPI For Erosive Esophagitis

Tegoprazan is superior to the proton pump inhibitor lansoprazole for healing erosive esophagitis as early as week 2, but one expert finds these results underwhelming.

Q&A: Progress in Thwarting ‘Chemobrain’

Recent trials suggest that simple steps during chemotherapy — including moderate exercise and a daily ibuprofen — may lessen treatment-related cognitive symptoms.

Second Cancer Rates Vary Widely Among Survivors

Not all cancer survivors face the same likelihood for a second cancer. New data show striking differences by age, cohort, and initial diagnosis.

A Verdict on Low-Dose Lithium for Cognitive Preservation?

Researchers hoped results from the latest trial on low-dose lithium would settle the question of lithium’s potential to preserve cognitive function. It didn’t.

Digital NHS Risks Leaving Older Patients Behind

Older people lack the skills, devices, or support to book GP appointments online — and many are giving up on trying.

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Latest News

Dr George Lundberg explains why treating equity as a banned political buzzword undermines the very foundations of public health and medical care.

Tegoprazan is superior to the proton pump inhibitor lansoprazole for healing erosive esophagitis as early as week 2, but one expert finds these results underwhelming.

Recent trials suggest that simple steps during chemotherapy — including moderate exercise and a daily ibuprofen — may lessen treatment-related cognitive symptoms.

Not all cancer survivors face the same likelihood for a second cancer. New data show striking differences by age, cohort, and initial diagnosis.

Researchers hoped results from the latest trial on low-dose lithium would settle the question of lithium’s potential to preserve cognitive function. It didn’t.

Older people lack the skills, devices, or support to book GP appointments online — and many are giving up on trying.

News All Time

Acetylcholinesterase Inhibitors May Lower Risk for Delirium

The continuous use of acetylcholinesterase inhibitors may reduce the risk for delirium in patients with dementia.

Semaglutide Associated Pancreatitis in a Woman

After a very high-fat iftar, a 57-year-old woman on semaglutide developed severe epigastric pain. Serum lipase was 3000 U/L, and CT showed peripancreatic fluid with early necrosis.

Why ‘Nurse’ is a Powerful Word on Social Media

Nurse influencers carry more professional weight than they may realise — and the profession needs to catch up.

The Oligo Movement: A New Era in Metastatic Lung Cancer

Dr Mark Kris discusses the rise of oligo-intervention in NSCLC and why a multidisciplinary approach is essential.

Pumping Iron May Aid Recovery After Breast Cancer Surgery

Strenuous weight training after breast cancer surgery is not only safe but also improves women’s strength, mobility, and balance, a study of one program finds.

Birth Plans Linked to Improved Maternal Outcomes

Patients with birth plans have higher rates of vaginal delivery and early breastfeeding.

GPs Losing £410 a Day to Hidden NHS Workload, Says RCGP

The RCGP says NHS system failures are costing GPs £410 a day in hidden workload — and nearly three quarters say it is compromising patient safety.

Using Magnetic Pulses to Rewire the Postpartum Brain

Repetitive transcranial magnetic stimulation is already FDA approved for major depressive disorder. Researchers think it could offer drug-free relief for moms.

Obstetric-Only Deaths in the US Fell After the Pandemic

Though the findings are encouraging, they notably exclude maternal deaths due to nonobstetric causes, which make up a substantial proportion of total maternal mortality.

GLP-1 Drugs May Cause Muscle Loss in Advanced Cirrhosis

GLP 1 drugs have been shown to cause significant skeletal muscle loss in patients with decompensated cirrhosis in proportion to their overall weight loss.

Obesity Drug Coverage Is Changing — What to Know Now

Some changes may make the medication more accessible, but the administrative burden will likely remain.

Regular Cannabis Use Linked to Symptoms of Menopause

Menopausal women may not be aware of the overlap between menopause symptoms and cannabis effects.

Data Trends: Heart Failure

Up to 15 million Americans are at risk of heart failure, with mortality rates rising in the US.

Novel Med Effective for Neuropathic Pain in Phase 3 Trial

Crisugabalin reduced pain and improved sleep, mood, and quality of life vs placebo in patients with central neuropathic pain.

Higher Dietary Fiber Tied to Lower Dementia Risk

Eating more fiber, especially soluble fiber, may significantly reduce the risk for dementia among older adults, results of a large, long-term observational study show.

PD-1 Inhibitors Linked to Better Outcomes in NK/T Lymphoma

A real-world study assesses survival outcomes when adding PD-1 inhibitors to asparaginase-based regimens in patients with extranodal natural killer/T-cell lymphoma.

Recommended News For You

Cancer Patients Are Receiving More and More Stupid Immunotherapy.

Discovery of breast cancer treatment resistance mechanism could lead to new hope for some

Reversing the toxic relationship with high doses of chemotherapy in oncology.

Assisted Dying Under Scrutiny From Medscape's Readers

Accuracy of Skin Cancer Diagnosis Varies by Physician, Exam Method

According to JAMA, even four minutes a day of exercise can lower the risk of cancer.

Researchers discuss HER2-low and HER2-zero in breast cancer

Recommended Articles For You

Managing High Potassium Levels: A Comprehensive Guide to Veltassa  

Unlocking Life Expectancy After Subdural Hematoma: A New Hope 

Unveiling Tumor Immunity: Pan-Cancer Proteogenomics Characterization 

Management of Relapsed Synovial Sarcoma: Current Treatment Strategies and Emerging Therapies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study finds 81% of cancer cures touted by TikTok videos are fake

2.

Dual imaging capsule captures 3D tissue and blood vessel changes for early esophageal cancer diagnosis

3.

Decrease seen in in situ breast cancer since 2009

4.

ICIs Show High Responses in Mediastinal B-Cell Lymphoma

5.

Housing aid linked to lower medical financial hardship among US renters with cancer

1.

Hepatocellular Carcinoma: Progress in Detection, Pathogenesis, and Treatment

2.

AI in Cancer Diagnostics and Imaging Interpretation

3.

Understanding the Rare Disease: Werner Syndrome Explained 

4.

Beyond the Organs: Navigating the Era of Tissue-Agnostic Therapies in Modern Cancer Management

5.

Exploring the Impact of Adrenal Myelolipoma on the Human Body

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

2.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

3.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II

4.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot